Multicentre validation of a prognostic index for overall survival in chronic lymphocytic leukaemia

Pietro Bulian, Michela Tarnani, Davide Rossi, Francesco Forconi, Giovanni Del Poeta, Francesco Bertoni, Emanuele Zucca, Marco Montillo, Gabriele Pozzato, Silvia Deaglio, Giovanni D'Arena, Dimitar Efremov, Roberto Marasca, Francesco Lauria, Valter Gattei, Gianluca Gaidano, Luca Laurenti

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

We wish to validate in a multicentric CLL population a nomogram and a risk score recently developed to predict overall survival (OS). Complete records from 1037 CLL patients were retrospectively collected to estimate OS and time to treatment (TTT). Cox models were used to test the independence of age, β-2-microglobulin, absolute lymphocyte count (ALC), sex, Rai stage and number of involved lymph node regions (LNR). Accuracy of prognostic models was tested with the concordance index (c-index). Median follow-up was 5.5 years, with 151 deaths and 475 treated patients. Median OS was not reached (65% survival rate at 13.9 years), median TTT was 6 years. We confirmed the ability of the prognostic score to predict OS and TTT in three risk groups, with results comparable with those reported in the original report. However, ALC and Rai stage were not independent predictors, whereas the Binet staging system, which incorporates LNR variable, showed independent predictive power; furthermore, both 5- and 10-year OS estimates from nomogram were lower compared to real data. When separately analysed, the impact of therapy on OS was not selected as independent predictor of OS in our series. According to these results, we proposed a simpler four-variable model (age, sex, Binet staging, β-2-microglobulin) and a new nomogram. This model had a c-index of 0.78 versus 0.76 of the six-variable model (p=0.043), showing better predictive accuracy. External validation and refinement are needed on independent data sets, possibly from cancer registry patients' series.

Original languageEnglish
Pages (from-to)91-99
Number of pages9
JournalHematological Oncology
Volume29
Issue number2
DOIs
Publication statusPublished - Jun 2011

Fingerprint

B-Cell Chronic Lymphocytic Leukemia
Survival
Nomograms
Lymphocyte Count
Lymph Nodes
Therapeutics
Proportional Hazards Models
Registries
Survival Rate
Population
Neoplasms

Keywords

  • Chronic lymphocytic leukaemia
  • Nomogram
  • Prognosis

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Cite this

Bulian, P., Tarnani, M., Rossi, D., Forconi, F., Del Poeta, G., Bertoni, F., ... Laurenti, L. (2011). Multicentre validation of a prognostic index for overall survival in chronic lymphocytic leukaemia. Hematological Oncology, 29(2), 91-99. https://doi.org/10.1002/hon.959

Multicentre validation of a prognostic index for overall survival in chronic lymphocytic leukaemia. / Bulian, Pietro; Tarnani, Michela; Rossi, Davide; Forconi, Francesco; Del Poeta, Giovanni; Bertoni, Francesco; Zucca, Emanuele; Montillo, Marco; Pozzato, Gabriele; Deaglio, Silvia; D'Arena, Giovanni; Efremov, Dimitar; Marasca, Roberto; Lauria, Francesco; Gattei, Valter; Gaidano, Gianluca; Laurenti, Luca.

In: Hematological Oncology, Vol. 29, No. 2, 06.2011, p. 91-99.

Research output: Contribution to journalArticle

Bulian, P, Tarnani, M, Rossi, D, Forconi, F, Del Poeta, G, Bertoni, F, Zucca, E, Montillo, M, Pozzato, G, Deaglio, S, D'Arena, G, Efremov, D, Marasca, R, Lauria, F, Gattei, V, Gaidano, G & Laurenti, L 2011, 'Multicentre validation of a prognostic index for overall survival in chronic lymphocytic leukaemia', Hematological Oncology, vol. 29, no. 2, pp. 91-99. https://doi.org/10.1002/hon.959
Bulian, Pietro ; Tarnani, Michela ; Rossi, Davide ; Forconi, Francesco ; Del Poeta, Giovanni ; Bertoni, Francesco ; Zucca, Emanuele ; Montillo, Marco ; Pozzato, Gabriele ; Deaglio, Silvia ; D'Arena, Giovanni ; Efremov, Dimitar ; Marasca, Roberto ; Lauria, Francesco ; Gattei, Valter ; Gaidano, Gianluca ; Laurenti, Luca. / Multicentre validation of a prognostic index for overall survival in chronic lymphocytic leukaemia. In: Hematological Oncology. 2011 ; Vol. 29, No. 2. pp. 91-99.
@article{3fd3310cbfc84fa8b9cc1fb5c438833c,
title = "Multicentre validation of a prognostic index for overall survival in chronic lymphocytic leukaemia",
abstract = "We wish to validate in a multicentric CLL population a nomogram and a risk score recently developed to predict overall survival (OS). Complete records from 1037 CLL patients were retrospectively collected to estimate OS and time to treatment (TTT). Cox models were used to test the independence of age, β-2-microglobulin, absolute lymphocyte count (ALC), sex, Rai stage and number of involved lymph node regions (LNR). Accuracy of prognostic models was tested with the concordance index (c-index). Median follow-up was 5.5 years, with 151 deaths and 475 treated patients. Median OS was not reached (65{\%} survival rate at 13.9 years), median TTT was 6 years. We confirmed the ability of the prognostic score to predict OS and TTT in three risk groups, with results comparable with those reported in the original report. However, ALC and Rai stage were not independent predictors, whereas the Binet staging system, which incorporates LNR variable, showed independent predictive power; furthermore, both 5- and 10-year OS estimates from nomogram were lower compared to real data. When separately analysed, the impact of therapy on OS was not selected as independent predictor of OS in our series. According to these results, we proposed a simpler four-variable model (age, sex, Binet staging, β-2-microglobulin) and a new nomogram. This model had a c-index of 0.78 versus 0.76 of the six-variable model (p=0.043), showing better predictive accuracy. External validation and refinement are needed on independent data sets, possibly from cancer registry patients' series.",
keywords = "Chronic lymphocytic leukaemia, Nomogram, Prognosis",
author = "Pietro Bulian and Michela Tarnani and Davide Rossi and Francesco Forconi and {Del Poeta}, Giovanni and Francesco Bertoni and Emanuele Zucca and Marco Montillo and Gabriele Pozzato and Silvia Deaglio and Giovanni D'Arena and Dimitar Efremov and Roberto Marasca and Francesco Lauria and Valter Gattei and Gianluca Gaidano and Luca Laurenti",
year = "2011",
month = "6",
doi = "10.1002/hon.959",
language = "English",
volume = "29",
pages = "91--99",
journal = "Hematological Oncology",
issn = "0278-0232",
publisher = "wiley",
number = "2",

}

TY - JOUR

T1 - Multicentre validation of a prognostic index for overall survival in chronic lymphocytic leukaemia

AU - Bulian, Pietro

AU - Tarnani, Michela

AU - Rossi, Davide

AU - Forconi, Francesco

AU - Del Poeta, Giovanni

AU - Bertoni, Francesco

AU - Zucca, Emanuele

AU - Montillo, Marco

AU - Pozzato, Gabriele

AU - Deaglio, Silvia

AU - D'Arena, Giovanni

AU - Efremov, Dimitar

AU - Marasca, Roberto

AU - Lauria, Francesco

AU - Gattei, Valter

AU - Gaidano, Gianluca

AU - Laurenti, Luca

PY - 2011/6

Y1 - 2011/6

N2 - We wish to validate in a multicentric CLL population a nomogram and a risk score recently developed to predict overall survival (OS). Complete records from 1037 CLL patients were retrospectively collected to estimate OS and time to treatment (TTT). Cox models were used to test the independence of age, β-2-microglobulin, absolute lymphocyte count (ALC), sex, Rai stage and number of involved lymph node regions (LNR). Accuracy of prognostic models was tested with the concordance index (c-index). Median follow-up was 5.5 years, with 151 deaths and 475 treated patients. Median OS was not reached (65% survival rate at 13.9 years), median TTT was 6 years. We confirmed the ability of the prognostic score to predict OS and TTT in three risk groups, with results comparable with those reported in the original report. However, ALC and Rai stage were not independent predictors, whereas the Binet staging system, which incorporates LNR variable, showed independent predictive power; furthermore, both 5- and 10-year OS estimates from nomogram were lower compared to real data. When separately analysed, the impact of therapy on OS was not selected as independent predictor of OS in our series. According to these results, we proposed a simpler four-variable model (age, sex, Binet staging, β-2-microglobulin) and a new nomogram. This model had a c-index of 0.78 versus 0.76 of the six-variable model (p=0.043), showing better predictive accuracy. External validation and refinement are needed on independent data sets, possibly from cancer registry patients' series.

AB - We wish to validate in a multicentric CLL population a nomogram and a risk score recently developed to predict overall survival (OS). Complete records from 1037 CLL patients were retrospectively collected to estimate OS and time to treatment (TTT). Cox models were used to test the independence of age, β-2-microglobulin, absolute lymphocyte count (ALC), sex, Rai stage and number of involved lymph node regions (LNR). Accuracy of prognostic models was tested with the concordance index (c-index). Median follow-up was 5.5 years, with 151 deaths and 475 treated patients. Median OS was not reached (65% survival rate at 13.9 years), median TTT was 6 years. We confirmed the ability of the prognostic score to predict OS and TTT in three risk groups, with results comparable with those reported in the original report. However, ALC and Rai stage were not independent predictors, whereas the Binet staging system, which incorporates LNR variable, showed independent predictive power; furthermore, both 5- and 10-year OS estimates from nomogram were lower compared to real data. When separately analysed, the impact of therapy on OS was not selected as independent predictor of OS in our series. According to these results, we proposed a simpler four-variable model (age, sex, Binet staging, β-2-microglobulin) and a new nomogram. This model had a c-index of 0.78 versus 0.76 of the six-variable model (p=0.043), showing better predictive accuracy. External validation and refinement are needed on independent data sets, possibly from cancer registry patients' series.

KW - Chronic lymphocytic leukaemia

KW - Nomogram

KW - Prognosis

UR - http://www.scopus.com/inward/record.url?scp=79959214932&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79959214932&partnerID=8YFLogxK

U2 - 10.1002/hon.959

DO - 10.1002/hon.959

M3 - Article

VL - 29

SP - 91

EP - 99

JO - Hematological Oncology

JF - Hematological Oncology

SN - 0278-0232

IS - 2

ER -